Gilead target price raised to $200 from $165
GILD•Maxim Group raised its target price for Gilead to $200 from $165.
Related News
Globalstar Q3 revenue falls on lower service sales, posts net loss
GSAT•
Retension Pharmaceuticals to participate in fireside chat at Guggenheim healthcare innovation conference
RTSN•
SCYNEXIS names Sanjay Subramanian chief financial officer
SCYX•
USA TODAY Co Q3 revenue falls 7.4%, misses estimates
TDAY•
Ralph Lauren raises annual forecasts on resilient luxury demand
RL•